EdiGene is a clinical-stage company focused on translating gene-editing technologies into transformative genetic medicines for patients with significant unmet medical needs. Anchored by its proprietary technologies of gene editing, bioinformatics, and high throughput genome-editing screening, EdiGene advances the pipeline on therapeutic platforms of LEAPER-based in vivo RNA base editing, ex vivo gene-editing hematopoietic stem cells, and ex vivo gene-editing T cells for allogeneic CAR-T.
Company Details
- Employees
- 47
- Founded
- -
- Address
- No. 22 Kexueyuan Road, Changping District,china
- Phone
- 010-8073 3899
- In****@****ene.com
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- http://www.edigene.com/
- HQ
- Beijing, Beijing
Edigene Inc. Questions
Edigene Inc.'s helpline number is 010-8073 3899
Edigene Inc.'s website is http://www.edigene.com/
Edigene Inc.'s LinkedIn profile is https://cn.linkedin.com/company/edigene
Edigene Inc. has
47 employees.
View email and phone details for 47
employees at Edigene Inc..
Edigene Inc.'s industry is
Biotechnology Research
Edigene Inc.'s top competitors are
Full Circles Therapeutics Inc.,
Profex,
Hebecell Corp,
Avery Therapeutics, Inc.,
Demeetra,
The Home Depot,
Allink Biotherapeutics,
Acrivon Therapeutics, Inc.,
Cytovia Therapeutics,
Cellorigin Biotech.
Edigene Inc.'s support email address is Info@edigene.com
Edigene Inc.'s categories are Biotechnology Research
Edigene Inc.'s founding year is 2015
